Earnings
PROCEPT BioRobotics Sales Rise 18% To $98.3 Million, But Quarterly Loss Widens To $26.5 Million
Procedures climbed about 22% in the third quarter, yet U.S. system sales were flat and the company held its 2026 outlook.
PROCEPT BioRobotics (PRCT) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
Procedures climbed about 22% in the third quarter, yet U.S. system sales were flat and the company held its 2026 outlook.
SEC Filings
The surgical-robot maker's quarterly report details a class action and a derivative suit, with losses it says it cannot estimate.
SEC Filings
An 8-K filed Friday names the Dallas-based thoracic surgeon, who has more than 1,100 peer-reviewed publications, as an independent director.